GEORGE JAMES: Open Payments
NPI 1992771455 · BURTONSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 26 payments from 10 companies in 2025. Trend: 2023 $354 · 2024 $553 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 5 | $122 |
| Lundbeck LLC | 4 | $82 |
| ABBVIE INC. | 3 | $78 |
| Vanda Pharmaceuticals Inc. | 3 | $53 |
| Supernus Pharmaceuticals, Inc. | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $16 |
Products named: ARISTADA, VRAYLAR, REXULTI, FANAPT, Qelbree, COBENFY, Auvelity, ABILIFY ASIMTUFII.
Industry payments across MD — which companies pay providers there.
